Incidence of bronchopulmonary dysplasia, growth failure, and pulmonary dysfunction assessed by clinical scoring

Area of Science:

• Neonatology
• Pediatric Pulmonology
• Clinical Medicine

Background:

• Bronchopulmonary dysplasia (BPD) is a chronic lung disease affecting preterm infants.
• Predicting long-term outcomes like home oxygen use and growth retardation is crucial for managing BPD.
• Current clinical scoring systems may not accurately reflect BPD severity for predictive purposes.

Purpose of the Study:

• To evaluate a clinical scoring system for predicting home supplemental oxygen needs and growth retardation in preterm infants with BPD.
• To identify reliable predictors of adverse outcomes in infants with bronchopulmonary dysplasia.

Main Methods:

• Retrospective analysis of 67 preterm infants with BPD.
• A five-variable clinical scoring system (inspiratory oxygen, CO2 partial pressure, respiratory rate, chest retractions, growth rate) was assessed.
• Correlation between the score, hours of high-concentration oxygen (>80%), and outcomes (home oxygen, growth retardation at 12 months) was examined.

Main Results:

• The clinical scoring system did not predict the need for home supplemental oxygen (P = .87) or growth retardation (P = .79).
• The number of hours of oxygen greater than 80% was significantly correlated with home oxygen use (P = .0001).
• High oxygen hours also significantly correlated with growth retardation at 1 year of age (P = .013).

Conclusions:

• A simple clinical scoring system is insufficient for predicting the functional severity of BPD.
• Individual clinical evaluation is necessary to determine pulmonary dysfunction, oxygen needs, and supportive care for at-risk infants before discharge.
• High-concentration oxygen exposure is a significant predictor of adverse outcomes in BPD.